South Korea, Japan and Taiwan rush to develop homegrown vaccines

Sluggish vaccination rollouts make the three places vulnerable to outbreaks

20210525 SK Vaccine

South Korean President Moon Jae-in inspects a vaccine vial at an SK Bioscience plant in the city of Andong on Jan. 20. His government has come under fire over a slow vaccine rollout. (Source photos by Reuters and EPA/Yonhap/Jiji)

KIM JAEWON, MITSURU OBE and LAULY LI, Nikkei staff writers

SEOUL/TOKYO/TAIPEI -- Chang Hyo-jung, a senior nurse at a general hospital in New York, is considering going back to her home country of South Korea in October for a four-week vacation. But it is unclear whether she will be able to avoid a two-week quarantine on arrival, even though she has been fully vaccinated with two Pfizer shots in the U.S.

"I wish I could see my family and friends without quarantine," Chang said.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.